Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s ...

With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

To fight off compounding pharmacies, Eli Lilly wants access to medical records of patients who used copycat products.

The success of Eli Lilly’s Zepbound, a challenger to Novo’s Wegovy, has prompted comparisons to a similar scenario, when ...

Politics, though controversial, this year presents one single theme that I think we can all agree on. Our government needs a ...

An investigation, published in the journal The BMJ, found that the newly U.S. Food & Drug Administration-approved donanemab is linked ...

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...

Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing ...

The Lilly Endowment Inc. keeps pouring into leaders, and Michelle Love thinks she has more she could pour out, too.

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...